Levidiotis, VickiFreeman, CraigTikellis, ChrisCooper, Mark EPower, David A2015-12-131320-5358http://hdl.handle.net/1885/82030Background: The β-D-endoglycosidase, heparanase, is emerging as an important contributor to the pathogenesis of proteinuria. The purpose of the present study therefore was to examine the role of heparanase in a model of accelerated anti-glomerular basemeKeywords: glomerulus basement membrane antibody; glycosidase; heparanase; heparanase antibody; messenger RNA; polyclonal antibody; unclassified drug; animal cell; animal experiment; animal model; animal tissue; antibody titer; antiglomerulus basement membrane disea Anti-glomerular basement membrane disease; Heparanase; ProteinuriaHeparanase inhibition reduces porteinuria in a model of accelerated anti-glomerular basement membrane antibody disease200510.1111/j.1440-1797.2005.00388.x2015-12-11